摘要
传统医药市场需求的不断扩大,已经引起全世界越来越多人们的关注和接受。美国食品药品管理局(FDA)新发布的《补充和替代医学产品及FDA管理指南》草案,标志着美国FDA对其他国家传统医药的认识和管理发生了变化。这不仅为我国中医药产品进入美国市场创造了有利条件,而且对我国中医药的国际化进程将产生积极的影响。
Traditional medicine market demand expanding continuously, has attracted more and more people＇s attention and acceptance. U.S. Food and Drug Administration issued ＂Complementary and Alternative Medicine Products and their Regulation＂. It has changed to knowledge and management to other countries in traditional medicine. It is not only to create favorable conditions that TCM enter the American market, but it will have a positive impact to the internationalization of TCM.
出处
《卫生软科学》
2008年第3期286-288,共3页
Soft Science of Health
基金
国家软科学项目"构建中医药保护的法律体系研究"(2006GXS2K022)
关键词
美国FDA
传统医药
管理政策
U.S. FDA
Traditional Medicine
Management Policy
